2O8M | Viral Protein | date | Dec 12, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of The S139a Mutant Of Hepatitis C Virus N Protease | ||||||||||||||
authors | T.O.Fischmann, A.J.Prongay, V.M.Madison, N.Yao | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Protease Chain: A, B Ec: 3.4.22.- Engineered: Yes Mutation: Yes |
Organism_scientific: Hepatitis C Virus Organism_taxid: 11103 Gene: Hcv Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Protease Chain: C, D Engineered: Yes |
Synthetic: Yes | ||||||||||||||
symmetry | Space Group: H 3 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.00 Å | ||||||||||||
ligand | NA, ZN | enzyme | Hydrolase E.C.3.4.22 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl] - 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization., Prongay AJ, Guo Z, Yao N, Pichardo J, Fischmann T, Strickland C, Myers J Jr, Weber PC, Beyer BM, Ingram R, Hong Z, Prosise WW, Ramanathan L, Taremi SS, Yarosh-Tomaine T, Zhang R, Senior M, Yang RS, Malcolm B, Arasappan A, Bennett F, Bogen SL, Chen K, Jao E, Liu YT, Lovey RG, Saksena AK, Venkatraman S, Girijavallabhan V, Njoroge FG, Madison V, J Med Chem. 2007 May 17;50(10):2310-8. Epub 2007 Apr 20. PMID:17444623 |
Data retrieval |
View 2O8M in 3D |
Visual 3D analysis of 2O8M |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2O8M |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |